Voyager Therapeutics GAAP EPS of -$0.46 beats by $0.07, collaboration revenue of $15.34M beats by $4.85M
Source: SeekingAlpha
2026-03-09 16:05:21 ET
- Voyager Therapeutics press release ( VYGR ): Q4 GAAP EPS of -$0.46 beats by $0.07 .
- Collaboration revenue of $15.34M (+144.3% Y/Y) beats by $4.85M .
- Cash, cash equivalents and marketable securities as of December 31, 2025, were $201.7 million.
Read the full article on Seeking Alpha
For further details see:
Voyager Therapeutics GAAP EPS of -$0.46 beats by $0.07, collaboration revenue of $15.34M beats by $4.85M
Voyager Therapeutics Inc.
NASDAQ: VYGR
VYGR Trading
-9.95% G/L:
$4.435 Last:
474,633 Volume:
$4.85 Open:
VYGR Latest News
March 09, 2026 04:01:00 pm
Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
VYGR Stock Data
$301,853,951
50,692,821
0.13%
37
N/A
Biotechnology & Life Sciences
Healthcare
US
Lexington
